Moshav Ofer, Israel

Gal Ben-Dror


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gal Ben-Dror: Innovator in Lipid Mixtures and Therapeutic Applications

Introduction

Gal Ben-Dror is a notable inventor based in Moshav Ofer, Israel. He has made significant contributions to the field of lipid mixtures, particularly in the context of therapeutic applications. His innovative work focuses on enhancing health through dietary nutrients and food supplements.

Latest Patents

Gal Ben-Dror holds a patent for "Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy." This patent describes various lipid mixtures, specifically special mixtures of fatty acids esters, which may include phytosterol esters and/or glyceride esters. The mixtures are evaluated for their ability to affect the levels of circulating LDL and HDL particles upon consumption. They also demonstrate therapeutic effects on conditions associated with lipid metabolism, such as atherosclerosis, diabetes, and metabolic disorders. Additionally, the patent covers compositions, dietary nutrients, food supplements, and nutraceuticals that comprise these innovative mixtures.

Career Highlights

Gal Ben-Dror is associated with Enzymotec Ltd., a company that focuses on developing innovative nutritional products. His work at Enzymotec has allowed him to explore the therapeutic potential of lipid mixtures and contribute to advancements in health and nutrition.

Collaborations

Some of his notable coworkers include Dorit Plat and Dori Pelled, who have collaborated with him on various projects related to lipid research and therapeutic applications.

Conclusion

Gal Ben-Dror's innovative work in lipid mixtures and their therapeutic applications highlights his commitment to improving health through scientific advancements. His contributions continue to influence the field of nutrition and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…